Mačak Šafranko Željka, Jakopec Lana, Svaguša Karla, Cvetko Krajinović Lidija, Tomasović Domagoj, Lukić Ljiljana, Markotić Alemka
Research Unit, University Hospital for Infectious Diseases "Dr. Fran Mihaljevic", 10000 Zagreb, Croatia.
Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Life (Basel). 2024 Apr 25;14(5):551. doi: 10.3390/life14050551.
Hemorrhagic fever with renal syndrome (HFRS) is a rodent-borne disease widespread in Europe and Asia. HFRS is caused by negative-sensed single-stranded RNA orthohantaviruses transmitted to humans through inhaling aerosolized excreta of infected rodents. Symptoms of HFRS include acute kidney injury, thrombocytopenia, hemorrhages, and hypotension. The immune response raised against viral antigens plays an important role in the pathogenesis of HFRS. Inhibitory co-receptors are essential in regulating immune responses, mitigating immunopathogenesis, and reducing tissue damage. Our research showed an increased soluble form of inhibitory co-receptors TIM-3, LAG-3, and PD-1 in HFRS patients associated with disease severity. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and the potential correlation with key clinical parameters. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and their possible association with relevant clinical parameters. Using multiplex immunoassay, we found elevated levels of TIM-3, LAG-3, and PD-1 proteins in the serum of HFRS patients. Furthermore, increased levels were associated with creatinine, urea, lactate dehydrogenase concentrations, and platelet count. These findings suggest that these proteins play a role in regulating the immune response and disease progression.
肾综合征出血热(HFRS)是一种在欧洲和亚洲广泛传播的鼠传疾病。HFRS由负链单股RNA正汉坦病毒引起,该病毒通过吸入受感染啮齿动物的气溶胶化排泄物传播给人类。HFRS的症状包括急性肾损伤、血小板减少、出血和低血压。针对病毒抗原产生的免疫反应在HFRS的发病机制中起重要作用。抑制性共受体在调节免疫反应、减轻免疫病理发生和减少组织损伤方面至关重要。我们的研究表明,HFRS患者中抑制性共受体TIM-3、LAG-3和PD-1的可溶性形式增加,且与疾病严重程度相关。我们的研究旨在调查HFRS对患者血清中抑制性受体TIM-3、LAG-3和PD-1可溶性形式浓度的影响以及与关键临床参数的潜在相关性。我们的研究旨在调查HFRS对患者血清中抑制性受体TIM-3、LAG-3和PD-1可溶性形式浓度的影响以及它们与相关临床参数的可能关联。通过多重免疫测定,我们发现HFRS患者血清中TIM-3、LAG-3和PD-1蛋白水平升高。此外,水平升高与肌酐、尿素、乳酸脱氢酶浓度和血小板计数相关。这些发现表明这些蛋白在调节免疫反应和疾病进展中起作用。